Bridgebio launches phase 1/2 of ‘4th generation EGFR TKI drug’ for lung cancer
Reporter Yoon So-young, biospectator ‘BBT-176′ is administered by three domestic institutions for patients with advanced non-small cell lung cancer.. Plan to enter a dose expansion tria…
